Tag: #CardiomyocyteProtection

Introduction Ischemic injury to heart cells remains a major challenge in cardiovascular medicine, often resulting in irreversible damage. A new study from the Artificial Cells & Organs Research Centre, McGill University, investigates a novel solution combining polyhemoglobin with synthetic enzymes—offering promising cardioprotective effects. Visit https://www.cardiologymedjournal.com/jccm for more groundbreaking research in this field. Revolutionizing Ischemic Cardioprotection…